I wouldn't read too much into the GAG response since it is in addition to ERT's. PAR would need to include kids not taking ERT's to evaluate DM, not sure why they didn't. GAG levels are also highly variable. Definitely can only see it being used as an adjuvant therapy. I don't see PAR commanding 50k per treatment cycle as others have indicated, but around 5k max. Unlikely to make the money back that we invested in R&D, so best to shelve the MPS project until someone pays for a license to use the data package. Who knows, maybe MPS is part of the cost cutting measures PAR are taking.
I wouldn't read too much into the GAG response since it is in...
-
- There are more pages in this discussion • 52 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
0.015(6.67%) |
Mkt cap ! $83.98M | |||
| Open | High | Low | Value | Volume |
| 22.5¢ | 24.0¢ | 22.5¢ | $173.6K | 743.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 99346 | 22.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 131244 | 5 |
View Market Depth
| Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |